| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2018-12-21 |
复牌提示：
2018-12-21 08:31:40 停牌，复牌日期 2018-12-24 00:00:01
|
| 2018-11-16 |
股东大会：
将于2018-12-20召开股东大会
会议内容 ▼▲
- 1.To adopt the Agreement and Plan of Merger, dated as of October 17, 2018 (which, as it may be amended from time to time, we refer to as the "merger agreement"), by and among Endocyte, Novartis AG, a company organized under the laws of Switzerland ("Novartis"), and Edinburgh Merger Corporation, a Delaware corporation and a wholly owned subsidiary of Novartis ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Endocyte (the "merger");
2.To approve, on an advisory (non-binding) basis, certain compensation that may be paid or become payable to Endocyte's named executive officers in connection with the merger (the "merger-related compensation");
3.To approve the adjournment of the special meeting, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve the proposal to adopt the merger agreement.
|
| 2018-11-16 |
详情>>
股本变动：
变动后总股本8209.76万股
|
| 2018-11-08 |
详情>>
业绩披露：
2018年三季报(累计)每股收益-0.5美元,归母净利润-3277.48万美元,同比去年增长29.52%
|
| 2018-08-01 |
详情>>
内部人交易：
Armour Alison A.股份减少1414.00股
|
| 2018-08-01 |
详情>>
业绩披露：
2018年中报每股收益-0.32美元,归母净利润-2016.73万美元,同比去年增长13.20%
|
| 2018-05-09 |
财报披露：
美东时间 2018-05-09 盘前发布财报
|
| 2018-05-09 |
详情>>
业绩披露：
2018年一季报每股收益-0.16美元,归母净利润-860.26万美元,同比去年增长25.12%
|
| 2018-03-23 |
股东大会：
将于2018-05-03召开股东大会
会议内容 ▼▲
- (1)To elect three directors to serve until the 2021 annual meeting of stockholders.
(2)To consider ratifying the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2018.
(3)To hold an advisory vote on executive compensation.
(4)To transact such other business as may properly come before the meeting.
|
| 2018-02-27 |
详情>>
业绩披露：
2017年年报每股收益-1.25美元,归母净利润-5506.41万美元,同比去年增长-25.47%
|
| 2018-02-27 |
详情>>
业绩披露：
2015年年报每股收益-0.98美元,归母净利润-4126.97万美元,同比去年增长-855.93%
|
| 2017-11-07 |
详情>>
业绩披露：
2017年三季报(累计)每股收益-1.09美元,归母净利润-4650.01万美元,同比去年增长-41.67%
|
| 2017-11-06 |
财报披露：
美东时间 2017-11-06 盘后发布财报
|
| 2017-08-09 |
详情>>
业绩披露：
2017年中报每股收益-0.55美元,归母净利润-2323.33万美元,同比去年增长3.66%
|
| 2017-08-08 |
财报披露：
美东时间 2017-08-08 盘后发布财报
|
| 2017-05-10 |
详情>>
业绩披露：
2017年一季报每股收益-0.27美元,归母净利润-1148.86万美元,同比去年增长-13.16%
|
| 2017-03-24 |
股东大会：
将于2017-05-04召开股东大会
会议内容 ▼▲
- (1)To elect four directors to serve until the 2020 annual meeting of stockholders.
(2)To consider ratifying the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2017.
(3)To hold an advisory vote on executive compensation.
(4)To hold an advisory vote regarding the frequency of future advisory votes on executive compensation.
(5)To transact such other business as may properly come before the meeting.
|
| 2017-03-13 |
详情>>
业绩披露：
2016年年报每股收益-1.04美元,归母净利润-4388.76万美元,同比去年增长-6.34%
|
| 2016-11-09 |
详情>>
业绩披露：
2016年三季报(累计)每股收益-0.78美元,归母净利润-3282.28万美元,同比去年增长-4.28%
|
| 2016-03-23 |
股东大会：
将于2016-05-05召开股东大会
会议内容 ▼▲
- 1.To elect three directors to serve until the 2019 annual meeting of stockholders.
2.To consider ratifying the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2016.
3.To transact such other business as may properly come before the meeting.
|
| 2015-04-02 |
股东大会：
将于2015-05-14召开股东大会
会议内容 ▼▲
- 1. To elect three directors to serve until the 2018 annual meeting of stockholders.
2. To consider ratifying the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2015.
3. To transact such other business as may properly come before the meeting.
|
| 2014-03-25 |
股东大会：
将于2014-05-15召开股东大会
会议内容 ▼▲
- 1. To elect four directors to serve until the 2017 annual meeting of stockholders.
2. To consider ratifying the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2014.
3. To hold an advisory vote on executive compensation.
4. To transact such other business as may properly come before the meeting.
|
| 2013-04-19 |
股东大会：
将于2013-06-19召开股东大会
会议内容 ▼▲
- 1. To elect three directors to serve until the 2016 annual meeting of stockholders.
2. To consider ratifying the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2013.
3. To transact such other business as may properly come before the meeting.
|